Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show
Spring on the Road
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Esperion Theraptc
(NQ:
ESPR
)
2.470
+0.060 (+2.49%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Esperion Theraptc
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
U.S. FDA Approves Broad New Labels for Esperion’s NEXLETOL® and NEXLIZET® to Prevent Heart Attacks and Cardiovascular Procedures in Both Primary and Secondary Prevention Patients, Regardless of Statin Use
March 22, 2024
From
Esperion Therapeutics
Via
Business Wire
U.S. FDA Approves Broad New Labels for NEXLETOL® and NEXLIZET® to Prevent Heart Attacks and Cardiovascular Procedures in Both Primary and Secondary Prevention Patients, Regardless of Statin Use
March 22, 2024
From
Esperion Therapeutics, Inc.
Via
GlobeNewswire
CHMP Issues Positive Opinions For Both Bempedoic Acid And The Bempedoic Acid / Ezetimibe Fixed-Dose Combination Tablet As Treatments For Hypercholesterolemia And Significantly Reducing Cardiovascular Events
March 22, 2024
From
Esperion Therapeutics, Inc.
Via
GlobeNewswire
Earnings Scheduled For February 27, 2024
February 27, 2024
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million.
Via
Benzinga
Earnings Preview: Esperion Therapeutics
February 26, 2024
Via
Benzinga
Peering Into Esperion Therapeutics's Recent Short Interest
January 30, 2024
Via
Benzinga
Esperion Reports Fourth Quarter and Full Year 2023 Financial Results
February 27, 2024
From
Esperion Therapeutics, Inc.
Via
GlobeNewswire
Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
February 16, 2024
From
Esperion Therapeutics, Inc.
Via
GlobeNewswire
Esperion to Report Fourth Quarter and Full Year 2023 Financial Results on February 27
February 13, 2024
From
Esperion Therapeutics, Inc.
Via
GlobeNewswire
RFK, Esperion Therapeutics Announce 2024 Promotional Schedule
February 01, 2024
NEXLETOL and NEXLIZET to Ride Along RFK Mustangs in Four Races in 2024
From
Esperion Therapeutics, Inc.
Via
GlobeNewswire
Esperion Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares
January 23, 2024
From
Esperion Therapeutics, Inc.
Via
GlobeNewswire
Why TransCode Therapeutics Shares Are Trading Lower By Over 24%? Here Are Other Stocks Moving In Friday's Mid-Day Session
January 19, 2024
Shares of TransCode Therapeutics, Inc. (NASDAQ: RNAZ) fell sharply during Friday’s session. TransCode Therapeutics priced a 5,942,623 share common stock offering at $1.22 per share. TransCode...
Via
Benzinga
Macy’s Layoffs 2024: What to Know About the Latest M Job Cuts
January 19, 2024
Macy's layoffs are in the news Friday as the retail company prepares to cut over 2,000 jobs and close down five of its stores.
Via
InvestorPlace
Topics
Workforce
Exposures
Layoff
Wayfair Layoffs 2024: What to Know About the Latest W Job Cuts
January 19, 2024
Wayfair layoffs have the e-commerce company planning to cut 13% of its workforce to reduce costs and streamline operations.
Via
InvestorPlace
Topics
Workforce
Exposures
Layoff
Why Is Esperion Therapeutics (ESPR) Stock Down 24% Today?
January 19, 2024
Esperion Therapeutics stock is down on Friday after the company announced a public offering for 56.7 million shares of ESPR.
Via
InvestorPlace
Why Super Micro Computer Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket
January 19, 2024
Shares of Super Micro Computer, Inc. (NASDAQ: SMCI) rose sharply in pre-market trading after the company announced updated financial guidance for the second-quarter, which surpassed its previou
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
January 19, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
January 19, 2024
We're starting the final day of trading this week with a look at the biggest pre-market stock movers for Friday morning!
Via
InvestorPlace
Esperion Announces Pricing of $85.1 Million Public Offering of Common Stock
January 18, 2024
From
Esperion Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
January 18, 2024
Via
Benzinga
Esperion Announces Proposed Public Offering of Common Stock
January 18, 2024
From
Esperion Therapeutics, Inc.
Via
GlobeNewswire
SolarEdge Technologies, Calavo Growers, Fisker And Other Big Stocks Moving Lower On Wednesday
January 17, 2024
U.S. stocks traded lower, with the Nasdaq Composite falling more than 150 points on Wednesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Wipro Shares Are Trading Higher By Over 16%? Here Are Other Stocks Moving In Friday's Mid-Day Session
January 12, 2024
Shares of Wipro Limited (NYSE: WIT) rose sharply during Friday’s session after the company reported third-quarter financial results, issued guidance and declared an interim dividend. Wipro shares...
Via
Benzinga
Why Airspan Networks Shares Are Trading Higher By Over 380%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
January 17, 2024
Shares of Airspan Networks Holdings Inc. (NASDAQ: MIMO) shares rose sharply during Wednesday’s session after the company announced a partnership with GCT Semiconductor to develop an RF module. Airspan...
Via
Benzinga
Nasdaq Down Over 100 Points; Sidus Space Shares Spike Higher
January 03, 2024
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling more than 100 points on Wednesday. The Dow traded down 0.52% to 37,518.35 while the NASDAQ fell 0.98% to 14,621.38....
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Wednesday's Intraday Session
January 03, 2024
Via
Benzinga
Why SoFi Technologies Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
January 03, 2024
Shares of SoFi Technologies, Inc. (NASDAQ: SOFI) fell sharply during Wednesday’s session after Keefe, Bruyette & Woods downgraded rating on the stock.
Via
Benzinga
Crude Oil Gains Over 3%; US Manufacturing Activity Contracts For 14th Consecutive Month
January 03, 2024
U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling around 150 points on Wednesday. The Dow traded down 0.79% to 37,417.28 while the NASDAQ fell 1.01% to 14,616.58. The...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why Pharmaceutical Company Esperion Therapeutics Shares Are Diving Today
January 03, 2024
Esperion Therapeutics, Inc. (NASDAQ: ESPR) shares are trading lower on Wednesday after the company announced a $125 million amendment to the collaboration with Japanese pharma company Daiichi Sankyo...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
January 03, 2024
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.